Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo
Authors:
- Barbara SchwertnerBSBarbara Schwertner
- Georg LindnerGLGeorg Lindner
- Camila Toledo StaunerCSCamila Toledo Stauner
- Elisa KlapprothEKElisa Klapproth
- Clara MagnusCMClara Magnus
- Anette RohrhoferARAnette Rohrhofer
- Beatrice Schuler-ThurnerBSBeatrice Schuler-Thurner
- Veronika ÖttlVÖVeronika Öttl
- Nicole FeichtgruberNFNicole Feichtgruber
- Konstantin DrexlerKDKonstantin Drexler
- Katja EvertKEKatja Evert
Open Access
Abstract
Talimogene laherparepvec (T-VEC), an oncolytic herpes simplex virus, is approved for intralesional injection of unresectable stage IIIB/IVM1a melanoma. However, it is still unclear which parameter(s) predict treatment response or failure. Our study aimed at characterizing surface receptors Nectin-1 and the herpes virus entry mediator (HVEM) in addition to intracellular molecules cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) as potential bio-markers for oncolytic virus treatment. In 20 melanoma cell lines, oncolytic activity of T-VEC was correlated with the expression of Nectin-1 but not HVEM, as evaluated via flow cytometry and immunohistochemistry. Knockout using CRISPR/Cas9 technology confirmed the superior role of Nectin-1 over HVEM for entry and oncolytic activity of T-VEC. Neither cGAS nor STING as evaluated by Western Blot and immunohistochemistry correlated with T-VEC induced oncolysis. The role of these biomarkers was retrospectively analyzed for the response of 35 cutaneous melanoma metastases of 21 patients to intralesional T-VEC injection, with 21 (60.0%) of these lesions responding with complete (n = 16) or partial regression (n = 5). Nectin-1 expression in pretreatment biopsies significantly predicted treatment outcome, while the expression of HVEM, cGAS, and STING was not prognostic. Altogether, Nectin-1 served as biomarker for T-VEC-induced melanoma regression in vitro and in vivo.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG HA 8481/1-1)
This publication has 40 references indexed in Scilit:
- Herpesvirus Entry Mediator and Nectin-1 Mediate Herpes Simplex Virus 1 Infection of the Murine CorneaJournal of Virology, 2011
- High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene AssaysPLOS ONE, 2011
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV MelanomaAnnals of Surgical Oncology, 2009
- Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1Proceedings of the National Academy of Sciences, 2009
- Unconventional ligand activation of herpesvirus entry mediator signals cell survivalProceedings of the National Academy of Sciences, 2009
- Nectin-1 Expression by Squamous Cell Carcinoma is a Predictor of Herpes Oncolytic SensitivityMolecular Therapy, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour propertiesGene Therapy, 2003
- Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell ResponseJournal of Experimental Medicine, 1998
- Detection of mutations by cleavage of DNA heteroduplexes with bacteriophage resolvasesNature Genetics, 1995